Summary by Futu AI
KINGSLEY BIOTECHNOLOGY CO., LTD. ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS DECIDED TO ESTABLISH A NEW COMMITTEE CALLED THE RISK MANAGEMENT AND ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEES TO STRENGTHEN THE COMPANY'S RISK MANAGEMENT AND ESG STRATEGY. The Committee shall consist of at least three members and shall be appointed by the Board of Directors, of which the Chairman must be a director appointed by the Board. The Secretary of the Committee shall be the Secretary of the Company or a designated person, and the statutory persons of the meeting shall be two members. The Committee meets at least once a year and oversees the company's risk management, internal control systems and ESG strategy. In addition, the Committee will review the Company's ESG reports and other related disclosures and make recommendations to the Board. The terms of reference of the Committee were approved by the Board in May 2022, and the name of the Committee was changed in May 2023 and the terms of office were further changed in March 2024.